INN Liraglutide
Dosage form: subcutaneous solution
Pharmacotherapeutic group: hypoglycemic medicine - glucagon-like peptide-1 analogue
Release form: in a pre-filled disposable injection pen 6 mg/ml (3pcs)
Instructions
Enligria® is the first Russian analogue of glucagon-like peptide-1 (aGLP-1), used in the treatment of type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular diseases.
